Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

被引：0
|
作者：
Devin, Francois [1 ]
Fourmaux, Eric [2 ]
Quentel, Gabriel [3 ]
Uzzan, Joel [4 ]
Quaranta El-Maftouhi, Maddalena [5 ]
Francais-Maury, Catherine [6 ]
Roquet, Wilfried [7 ]
Castelnovo, Laurent [8 ]
Razavi, Sam [9 ]
Finzi, Laetitia [10 ]
机构：
[1] Ctr Monticelli Paradis, Ophtalmol, Marseille, France
[2] Palais Galien, Ophtalmol, Bordeaux, France
[3] Ctr Imagerie & Laser, Paris, France
[4] Clin Mathilde, Ophtalmol, Rouen, France
[5] Ctr Rabelais, Ophtalmol, Lyon, France
[6] Ctr Odeon, Ophtalmol, Paris, France
[7] Ctr Blatin, Ophtalmol, Clermont Ferrand, France
[8] Clin Maison Rouge, Ophtalmol, Strasbourg, France
[9] Clin St Gatien, Ophtalmol, Tours, France
[10] Novartis Pharma SAS, Retine, Rueil Malmaison, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3353
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Evaluation of time-to-recurrence of disease activity in treatment-naive patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study
    Quaranta, Maddalena
    Devin, Francois
    Quentel, Gabriel
    Uzzan, Joel
    Fourmaux, Eric
    Castelnovo, Laurent
    Roquet, Wilfried
    Francais-Maury, Catherine
    Razavi, Sam
    San Nicolas, Nathalie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [3] AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: PROSPECTIVE PILOT STUDY
    Udaondo, Patricia
    Garcia-Delpech, Salvador
    Salom, David
    Hervas-Ontiveros, Ana
    Diaz-Cespedes, Ricardo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration in treatment-naive patients
    Pedersen, Karen Bjerg
    Sjolie, Anne Katrin
    Moller, Flemming
    [J]. ACTA OPHTHALMOLOGICA, 2009, 87 (07) : 714 - 719
  • [5] The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
    Garcia-Quintanilla, Laura
    Almuina-Varela, Pablo
    Rodriguez-Cid, Maria Jose
    Gil-Martinez, Maria
    Abraldes, Maximino J.
    Gomez-Ulla, Francisco
    Gonzalez-Barcia, Miguel
    Mondelo-Garcia, Cristina
    Estany-Gestal, Ana
    Otero-Espinar, Francisco J.
    Fernandez-Rodriguez, Maribel
    Fernandez-Ferreiro, Anxo
    [J]. PHARMACEUTICS, 2024, 16 (01)
  • [6] Cost of epimacular brachytherapy for treatment-naive neovascular age-related macular degeneration
    Jackson, Timothy L.
    Kirkpatrick, Lucy
    Tang, Genevieve
    Prasad, Somdutt
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (12) : 1533 - 1534
  • [7] RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Results From LUMINOUS, a Global Real-World Study
    Holz, Frank G.
    Figueroa, Marta S.
    Bandello, Francesco
    Yang, Yit
    Ohji, Masahito
    Dai, Hong
    Wykrota, Halina
    Sharma, Sanjay
    Dunger-Baldauf, Cornelia
    Lacey, Sue
    Macfadden, Wayne
    Mitchell, Paul
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (09): : 1673 - 1685
  • [8] A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Diack, Cheikh
    Schwab, Dietmar
    Cosson, Valerie
    Buchheit, Vincent
    Mazer, Norman
    Frey, Nicolas
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (06):
  • [9] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [10] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
12345